Experimental Hematology
Volume 38, Issue 7 , Pages 581-592 , July 2010

Stem cell plasticity revisited: The continuum marrow model and phenotypic changes mediated by microvesicles

  • Peter J. Quesenberry

      Affiliations

    • Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI., USA
    • ,
  • Mark S. Dooner

      Affiliations

    • Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI., USA
    • ,
  • Jason M. Aliotta

      Affiliations

    • Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI., USA
    • Division of Pulmonary, Sleep and Critical Care Medicine, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI., USA
    • Corresponding Author InformationOffprint requests to: Jason M. Aliotta, M.D., Division of Hematology/Oncology, Rhode Island Hospital, 3rd Floor George Building, 593 Eddy Street, Providence, RI 02903

Received 27 February 2010 ,Revised 27 February 2010 ,Accepted 31 March 2010.

References 

  1. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961;14:213–222
  2. Till JE, McCulloch EA, Siminovitch LA. Stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc Natl Acad Sci U S A. 1964;51:29–36
  3. Habibian HK, Peters SO, Hsieh CC, et al. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J Exp Med. 1998;188:393–398
  4. Cerny J, Dooner M, McAuliffe C, et al. Homing of purified murine lymphohematopoietic stem cells: a cytokine-induced defect. J Hematother Stem Cell Res. 2002;11:913–922
  5. Colvin GA, Dooner MS, Dooner GJ, et al. Stem cell continuum: directed differentiation hotspots. Exp Hematol. 2007;35:96–107
  6. Colvin GA, Lambert JF, Carlson JE, McAuliffe CI, Abedi M, Quesenberry PJ. Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static cultures. Vitro Cell Dev Biol Anim. 2002;38:343–351
  7. Colvin GA, Lambert JF, Moore BE, et al. Intrinsic hematopoietic stem cell/progenitor plasticity: inversions. J Cell Physiol. 2004;199:20–31
  8. Reddy GP, Tiarks CY, Pang L, Wuu J, Hsieh CC, Quesenberry PJ. Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells. Blood. 1997;90:2293–2299
  9. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol. 1995;23:461–469
  10. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood. 1996;87:30–37
  11. Becker PS, Nilsson SK, Li Z, et al. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: Modulation by cytokines and cell cycle status. Exp Hematol. 1999;27:533–541
  12. Berrios VM, Dooner GJ, Nowakowski G, et al. The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells. Exp Hematol. 2001;29:1326–1335
  13. Reddy GP, McAuliffe CI, Pang L, Quesenberry PJ, Bertoncello I. Cytokine receptor repertoire and cytokine responsiveness of Ho dull / Rh dull stem cells with differing potentials for G1/S phase progression. Exp Hematol. 2002;30:792–800
  14. Quesenberry PJ, Dooner GJ, Tatto MD, Colvin GA, Johnson K, Dooner MS. Expression of cell cycle related genes with cytokine-induced cell cycle progression of primitive hematopoietic stem cells. Stem Cells Dev. 2010;19:453–460
  15. Colvin GA, Berz D, Liu L, et al. Heterogeneity of non-cycling and cycling synchronized murine hematopoietic stem/progenitor cells. J Cell Physiol. 2010;222:57–65
  16. Dooner MS, Aliotta JM, Pimentel J, et al. Conversion potential of marrow cells into lung cells fluctuates with cytokine-induced cell cycle. Stem Cells Dev. 2008;17:207–219
  17. Quesenberry PJ, Colvin GA, Lambert JF, et al. The new stem cell biology. Trans Am Clin Climatol Assoc. 2002;113:182–206discussion 206−207
  18. Quesenberry PJ, Habibian H, Dooner M, et al. Physical and physiological plasticity of hematopoietic stem cells. Blood Cells Mol Dis. 2001;27:934–937
  19. Quesenberry PJ, Colvin GA, Lambert JF. The chiaroscuro stem cell: a unified stem cell theory. Blood. 2002;15:4266–4271
  20. Quesenberry PJ, Colvin G, Lambert JF, et al. Marrow stem cell potential within a continuum. Ann N Y Acad Sci. 2003;996:209–221
  21. Quesenberry PJ, Colvin GA, Abedi M, et al. The marrow stem cell: the continuum. Bone Marrow Transplant. 2003;32(Suppl 1):S19–S22
  22. Quesenberry PJ, Dooner G, Colvin G, Abedi M. Stem cell biology and the plasticity polemic. Exp Hematol. 2005;33:389–394
  23. Quesenberry PJ, Abedi M, Dooner M, et al. The marrow cell continuum: stochastic determinism. Folia Histochem Cytobiol. 2005;43:187–190
  24. Quesenberry PJ. The continuum model of marrow stem cell regulation. Curr Opin Hematol. 2006;13:216–221
  25. Quesenberry PJ, Dooner G, Dooner M, Colvin G. The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells. Stem Cell Rev. 2005;1:29–36
  26. Quesenberry PJ, Colvin G, Dooner G, Dooner M, Aliotta JM, Johnson K. The stem cell continuum: cell cycle, injury, and phenotype lability. Ann N Y Acad Sci. 2007;1106:20–29
  27. Quesenberry PJ, Aliotta JM. The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles. Stem Cell Rev. 2008;4:137–147
  28. Quesenberry PJ, Dooner GJ, Dooner MS. Problems in the Promised Land: status of adult marrow stem cell biology. Exp Hematol. 2009;37:775–783
  29. Becker AJ, McCulloch EA, Siminovitch L, Till JE. The effect of differing demands for blood cell production on DNA synthesis by hemopoietic colony-forming cells of mice. Blood. 1965;5:5
  30. Lajtha LG, Pozzi LV, Schofield R, Fox M. Kinetic properties of hemopoietic stem cells. Cell Tissue Kinet. 1969;2:39
  31. Frindel E, Leuchars E, Davis AJS. Thymus dependency of bone marrow stem cell proliferation in response to certain antigens. Exp Hematol. 1976;4:275
  32. Lord BI. Haemopoietic stem cells. In:  Potten CS editors. Stem cells: their identification and characterization. Edinburgh: Churchill Livingston; 1983;p. 118
  33. Gidali J, Istvan E, Fehr I. Long-term perturbation of hemopoiesis after moderate damage to stem cells. Exp Hematol. 1985;13:647–651
  34. Croizat H, Frindel E, Tubiana M. Antigenic stimulation of DNA synthesis in the haematopoietic stem cells of axenic mice. Nature. 1970;228:1187–1188
  35. Croizat H, Frindel E, Tubiana M. Proliferative activity of stem cells in the bone-marrow of mice after single and multiple irradiations (total-or partial-body exposure). Int J Radiat Biol. 1970;18:347–358
  36. Vassort F, Winterholer M, Frindel E, Tubiana M. Kinetic parameters of bone marrow stem cells using in vivo suicide by tritiated thymidine or hydroxyurea. Blood. 1973;41:789–796
  37. Lord BI, Lajtha LG, Gidali J. Measurement of the kinetic status of bone marrow precursor cells: three cautionary tales. Cell Tissue Kinet. 1974;7:507–515
  38. Guigon M, Sainteny F, Dumenil D, Lepault F, Frindel E. Response of quiescent and cycling CFU to stimulation. Exp Hematol. 1978;6:270–272
  39. Wu AM. A method for measuring the generation time and length of DNA synthesizing phase of clonogenic cells in a heterogeneous population. Cell Tissue Kinet. 1981;14:39–52
  40. Monette FC, Demers ML. An alternate method for determining the proliferative status of transplantable murine stem cells. Exp Hematol. 1982;10:307–313
  41. Boersma WJA. Radiation sensitivity and cycling status of mouse bone marrow prothymocytes and day 8 colony forming units spleen (CFUs). Exp Hematol. 1983;11:922–930
  42. Monette F, Holden SA, Sheehy MJ, Matzinger EA. Specificity of hemin action in vivo at early stages of hematopoietic cell differentiation. Exp Hematol. 1984;12:782–787
  43. Inoue T, Cronkite EP, Commerford SL, Carsten AL. Residual toxicity in hematopoietic cells following a single dose of methylnitrosourea. Leuk Res. 1984;8:105–116
  44. Wdzieczak-Bakala J, Pines M, Guigon M, Lenfant M. Cyclic AMP response to various haemopoietic regulators. Cell Tissue Kinet. 1985;18:297–306
  45. Quesenberry PJ, Stanley K. A statistical analysis of murine stem cell suicide techniques. Blood. 1980;56:1000–1005
  46. Necas E, Znojil V. CFU-S content and cycling rate in several strains of mice. Exp Hematol. 1987;15:759–764
  47. Forsberg EC, Prohaska SS, Katzman S, Heffner GC, Stuart JM, Weissman IL. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet. 2005;1:e28
  48. Rossi DJ, Bryder D, Zahn JM, et al. Cell Intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A. 2005;102:9194–9199
  49. Arber C, BitMansour A, Sparer TE, et al. Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood. 2003;102:421–428
  50. Manz MG, Miyamoto T, Akashi K, Weissman IL. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872–11877
  51. Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, Weissman IL, et al. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell. 2002;3:137–147
  52. Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A. 2001;98:14541–14546
  53. Kondo M, Scherer DC, King AG, Manz MG, Weissman IL. Lymphocyte development from hematopoietic stem cells. Curr Opin Genet Dev. 2001;11:520–526
  54. Kondo M, Scherer DC, Miyamoto T, et al. Cell fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000;407:383–386
  55. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193–197
  56. Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A. 1999;96:3120–3125
  57. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91:661–672
  58. Morrison SJ, Wandycz AM, Hemmati HD, Wright DE, Weissman IL. Identification of lineage of multipotent hematopoietic progenitors. Development. 1997;124:1929–1939
  59. Adolfsson J, Mansson R, Buza-Vidas N, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential: a revised road map for adult blood lineage commitment. Cell. 2005;121:295–306
  60. Randal TD, Lund FE, Howard MD, Weissman IL. Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood. 1996;87:4057–4067
  61. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1994;1:661–673
  62. Forsberg EC, Bhattacharya D, Weissman IL. Hematopoietic stem cells: expression profiling and beyond. Stem Cell Rev. 2006;2:23–30
  63. Warren L, Bryder D, Weissman IL, Quake SR. Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR. Proc Natl Acad Sci U S A. 2006;103:17807–17812
  64. Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol. 2006;169:338–463[Erratum in: Am J Pathol. 2006;169:1899]
  65. Forsberg EC, Serwold T, Kogan S, Weissman IL, Passegue E. New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell. 2006;126:415–426
  66. Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med. 2005;202:1599–1611
  67. Wagers AJ, Weissman IL. Differential expression of alpha2 integrin separates long-term and short-term reconstituting Lin-/loThy1.1(lo)c-kit+ Sca-1 hematopoietic stem cells. Stem Cells. 2006;24:1087–1094
  68. Bradford GB, Williams B, Rossi R, Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol. 1997;25:445–453
  69. Pang L, Reddy PV, McAuliffe CI, Colvin GA, Quesenberry PJ. Studies on BrdU labeling of hematopoietic cells: stem cells and cell lines. J Cell Physiol. 2003;197:251–260
  70. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol. 1993;122:897–902
  71. Wilson A, Laurenti E, Oser G, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008;135:1118–1129
  72. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797–1806
  73. Orschell-Traycoff CM, Hiatt K, Dagher RN, Rice S, Yoder MC, Srour EF. Homing and engraftment potential of Sca+lin- cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood. 2000;96:1380–1387
  74. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229–1234
  75. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow derived hepatocytes. Nature. 2003;422:897–901
  76. Quesenberry PJ, Dooner G, Dooner M, Abedi M. Ignoratio Elenchi: red herrings in stem cell research. Science. 2005;308:1121–1122
  77. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell. 2002;111:589–601
  78. Bittner RE, Schofer C, Weipoltshammer K, et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl). 1999;199:391–396
  79. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390–394
  80. Abedi M, Greer DA, Colvin GA, et al. Tissue injury in marrow transdifferentiation. Blood Cells Mol Dis. 2004;32:42–46
  81. Abedi M, Greer DA, Colvin GA, et al. Robust conversion of marrow cells to skeletal muscle with formation of marrow-derived muscle cell colonies: a multifactorial process. Exp Hematol. 2004;32:426–434
  82. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of α-sarcoglycan null dystrophic mice through intra-arterial delivery of mesangioblasts. Science. 2003;301:487–492
  83. Abe S, Lauby G, Boyer C, Rennard S, Sharp J. Transplanted BM and BM side population cells contribute progeny to the lung and liver in irradiated mice. Cytotherapy. 2003;5:523–533
  84. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41–49
  85. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369–377
  86. Aliotta JM, Keaney P, Passero M, et al. Bone marrow production of lung cells: the impact of G-CSF, cardiotoxin, graded doses of irradiation, and subpopulation phenotype. Exp Hematol. 2006;34:230–241
  87. Weimann JM, Johansson CB, Trejo A, Blau HM. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol. 2003;5:959–966
  88. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003;425:968–973
  89. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest. 2003;111:843–850
  90. Newsome PN, Johannessen I, Boyle S, et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cell fusion. Gastroenterology. 2003;124:1891–1900
  91. Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004;200:123–135
  92. Bailey AS, Jiang A, Afentoulis M, et al. Transplanted adult hematopoietic stem cells differentiate into functional endothelial cells. Blood. 2004;103:13–19
  93. Masuya M, Drake CJ, Fleming PA, et al. Hematopoietic origin of glomerular mesangial cells. Blood. 2003;101:2215–2218
  94. Harris RG, Herzog EL, Bruscia EM, Grove JE, Van Arnam JS, Krause DS. Lack of a fusion requirement in bone marrow derived epithelia. Science. 2004;305:90–93
  95. Ogawa M, LaRue AC, Drake CJ. Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. Blood. 2006;108:2893–2896
  96. Lang H, Ebihara Y, Schmiedt RA, et al. Contribution of bone marrow hematopoietic stem cells to adult mouse inner ear: mesenchymal cells and fibrocytes. J Comp Neurol. 2006;496:187–201
  97. Dooner MS, Aliotta JM, Pimentel J, et al. Conversion potential of marrow cells into lung cell fluctuates with cytokine-induced cell cycle. Stem Cells Dev. 2008;17:207–219
  98. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell. 1997;8:2631–2645
  99. Théry C, Regnault A, Garin J, et al. Molecular characterization of dendritic cell-derived exosomes: selective accumulation of the heat shock protein hsc73. J Cell Biol. 1999;147:599–610
  100. Mears R, Craven RA, Hanrahan S. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics. 2004;4:4019–4031
  101. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412–9420
  102. Van Niel G, Raposo G, Candalh C, et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology. 2001;121:337–349
  103. Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161–1172
  104. Fauré J, Lachenal G, Court M, et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci. 2006;31:642–648
  105. Keller S, Sanderson MP, Stoeck A. Exosomes: from biogenesis and secretion to biological function. Immunol Lett. 2006;107:102–108
  106. Fader CM, Colombo MI. Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ. 2009;16:70–78
  107. Morel O, Toti F, Hugel B, Frevssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol. 2004;11:156–164
  108. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sizma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94:3791–3799
  109. Nomura S, Nakamura T, Cone J, Tandon NN, Kambayashi J. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry. 2000;40:173–181
  110. Janowska-Wieczorek A, Majka M, Kijowski J, et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood. 2001;98:3143–3149
  111. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nature Rev Immunol. 2009;9:581–593
  112. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumor cells and transfer some of these determinants to monocytes. Cancer Immunol Imunother. 2006;55:808–818
  113. Rozmyslowicz T, Majka M, Kijowski J, et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS. 2003;17:33–42
  114. Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 2004;64:7045–7049
  115. Fackler OT, Peterlin BM. Endocytic entry of HIV-1. Curr Biol. 2000;10:1005–1008
  116. Fevrier B, Vilette D, Archer F. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A. 2004;100:10592–10597
  117. Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006;20:847–856
  118. Holmgren L, Szeles A, Rajnavolgyi R, et al. Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood. 1999;93:3956–3963
  119. Hakelien AM, Landsverk HB, Rob JM, Skålhegg BS, Collas P. Reprogramming fibroblasts to express T-cell functions using cell extracts. Nat Biotech. 2002;20:460–466
  120. Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007;110:2440–2448
  121. Prokopi M, Pula G, Mayr U, et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009;114:723–732
  122. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol. 2004;6:532–539
  123. Aliotta JM, Sanchez-Guijo FM, Dooner GJ, et al. Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells. 2007;25:2245–2256
  124. Aliotta JM, Pereira M, Johnson KW, et al. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol. 2010;38:233–245
  125. Renzulli JF, DelTatto M, Dooner G, et al. Microvesicle induction of prostate specific gene expression in normal human bone marrow cells. J Urol. In press.
  126. Del Tatto M, Ng T, Aliotta JM, et al. Marrow cell genetic phenotype change induced by human lung cancer cells. J Clin Oncol. 2009;27:15s;Abstract 11108

PII: S0301-472X(10)00143-8

doi: 10.1016/j.exphem.2010.03.021

Experimental Hematology
Volume 38, Issue 7 , Pages 581-592 , July 2010

Article Tools

* Image Usage & Resolution